Recent Study: The Contract Biomanufacturing Market Outlook to 2017
The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a 20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing market is forecast to grow 9% per year over the same period.
View full press release